Maison Solutions Class A Common StockNASDAQ: MSS

Profile

Country:

United States

IPO:

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$19.38 M
-93%vs. 3y high
21%vs. sector
-vs. 3y high
-vs. sector
-94%vs. 3y high
52%vs. sector
-95%vs. 3y high
21%vs. sector

Price

regular market | Fri, 25 Oct 2024 20:00:01 GMT
$0.98+$0.02(+2.49%)

Dividend

No data over the past 3 years
$29.65 M$700.90 K

Analysts recommendations

Institutional Ownership

MSS Latest News

Maison Solutions Reports First Quarter 2025 Financial Results
accesswire.com23 September 2024 Sentiment: POSITIVE

MONTEREY PARK, CA / ACCESSWIRE / September 23, 2024 / Maison Solutions Inc. (NASDAQ:MSS) ("Maison Solutions" or the "Company"), a U.S.-based specialty grocery retailer offering traditional Asian and international food and merchandise, today announced financial results for the first quarter ended July 31, 2024. Management Commentary "We are pleased with our financial results for Q1 2025, as it marked the first full quarter with Lee Lee included under the Maison Solutions umbrella," said John Xu, President, Chairman and Chief Executive Officer of Maison Solutions.

Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
globenewswire.com16 September 2024 Sentiment: POSITIVE

- Confirmed partial responses (PRs) doubled to four since ASCO GI in MSS CRC patients without liver and peritoneal metastases for overall response rate (ORR) of 24% (4/17) with ADG126 10 mg/kg every three weeks (Q3W) in combination with pembrolizumab -

Syndax Announces Plans to Advance into Phase 1b Portion of Trial Evaluating Revumenib in Relapsed or Refractory Metastatic MSS CRC
prnewswire.com06 June 2024 Sentiment: POSITIVE

– IDMC recommendation to advance based on favorable safety profile observed in Phase 1a portion of trial – WALTHAM, Mass. , June 6, 2024 /PRNewswire/ -- Syndax Pharmaceuticals (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that it has advanced into the Phase 1b portion of its Phase 1/2 proof-of-concept trial of revumenib, the Company's highly selective, oral menin inhibitor, as a monotherapy in patients with relapsed or refractory (R/R) metastatic microsatellite stable (MSS) colorectal cancer (CRC).

Breakthrough Data on Botensilimab/Balstilimab in MSS CRC Presented at the 2024 ASCO Annual Meeting
businesswire.com23 May 2024 Sentiment: POSITIVE

LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced a novel analysis from the Phase 1b trial of botensilimab in combination with balstilimab (BOT/BAL) in relapsed/refractory microsatellite stable colorectal cancer (r/r MSS CRC) with no active liver metastases (NLM) will be presented at the upcoming 2024 American Society of Clinical Oncology (ASCO) Annual Meeting on June 1, 2024. The.

Maison Solutions Readies $12 Million U.S. IPO
Seeking Alpha24 May 2023 Sentiment: NEUTRAL

Maison Solutions has filed proposed terms for a $12 million U.S. IPO. The firm operates four Asian-American supermarkets in Los Angeles and seeks to expand.

What type of business is Maison Solutions Class A Common Stock?

Maison Solutions Inc., together with its subsidiaries, operates as a specialty grocery retailer in the United States. The company offers perishable products, such as meat, seafood, vegetables, and fruit; non-perishable products, including grocery products comprising cooking utensils, canned foods, Chinese and Asian seasonings and spices, and snacks, as well as liquor, cigarette, lottery, newspaper, reusable bag, non-food, and health products; and general merchandise, beauty care, pharmacy, fuel, and other items and services in its stores. It also offers its products online. The company was formerly known as Maison International, Inc. and changed its name to Maison Solutions Inc. in September 2021. Maison Solutions Inc. was incorporated in 2019 and is headquartered in Monterey Park, California.

What sector is Maison Solutions Class A Common Stock in?

Maison Solutions Class A Common Stock is in the Consumer Defensive sector

What industry is Maison Solutions Class A Common Stock in?

Maison Solutions Class A Common Stock is in the Grocery Stores industry

What country is Maison Solutions Class A Common Stock from?

Maison Solutions Class A Common Stock is headquartered in United States

What is Maison Solutions Class A Common Stock website?

https://maisonsolutionsinc.com

Is Maison Solutions Class A Common Stock in the S&P 500?

No, Maison Solutions Class A Common Stock is not included in the S&P 500 index

Is Maison Solutions Class A Common Stock in the NASDAQ 100?

No, Maison Solutions Class A Common Stock is not included in the NASDAQ 100 index

Is Maison Solutions Class A Common Stock in the Dow Jones?

No, Maison Solutions Class A Common Stock is not included in the Dow Jones index

When was Maison Solutions Class A Common Stock the previous earnings report?

No data

When does Maison Solutions Class A Common Stock earnings report?

Next earnings report date is not announced yet